Skip to Main Content

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan

2019

This study investigates the feasibility and cost of hepatitis C virus (HCV) elimination in Pakistan using a decision analytical model and microsimulation techniques from 2015 to 2030. Various scenarios, including the status quo and seven elimination strategies, were evaluated based on Pakistan-specific variables. Main outcomes included trends in HCV prevalence, mortality, disability-adjusted life-years, and total costs of HCV care. Results suggest that to achieve HCV elimination by 2030, significant scale-up of testing and treatment is necessary, with at least 25 million people needing testing and 700,000 individuals requiring treatment annually. Compared to the status quo, the elimination scenario could prevent a substantial number of liver-related deaths and HCV-associated disability-adjusted life-years, leading to cost savings of $2.6 billion from 2018 to 2030. The study concludes that while HCV elimination in Pakistan may be challenging, strategic planning and governmental support could facilitate its achievement.

 

Source:

Chhatwal J, Chen Q, Wang X et al. Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan. JAMA Network Open 2019; 2 (5): e193613. https://doi.org/10.1001/jamanetworkopen.2019.3613